DA
DCF Advisers Portfolio holdings
AUM
$208M
This Quarter Return
-12.41%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$116M
AUM Growth
+$116M
(-11%)
Cap. Flow
+$13.9M
Cap. Flow
% of AUM
12.05%
Top 10 Holdings %
Top 10 Hldgs %
50.03%
Holding
73
New
14
Increased
21
Reduced
11
Closed
5
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
$2.74M |
| 2 |
VanEck Gold Miners ETF
GDX
|
$2.07M |
| 3 |
Verizon
VZ
|
$1.34M |
| 4 |
Cisco
CSCO
|
$1.28M |
| 5 |
Incyte
INCY
|
$1.08M |
Top Sells
| 1 |
Home Depot
HD
|
$2.18M |
| 2 |
Ovintiv
OVV
|
$1.28M |
| 3 |
Macy's
M
|
$1.28M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$1.2M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$610K |
Sector Composition
| 1 | Healthcare | 40.55% |
| 2 | Technology | 19.24% |
| 3 | Communication Services | 11.82% |
| 4 | Financials | 8.56% |
| 5 | Consumer Discretionary | 2.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
SPDR Gold Trust
GLD
$107B
| $9.62M | 6.3% | 65,000 | – | – |
|
2
Alphabet (Google) Class C
GOOG
$2.58T
| $7.5M | 4.91% | 6,450 +700 | +12% | +$814K |
|
3
Micron Technology
MU
$133B
| $6.84M | 4.47% | 162,500 +12,500 | +8% | +$526K |
|
|
ITCI
4
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.65M | 4.35% | 432,500 -35,573 | -8% | -$547K |
|
|
5
Regeneron Pharmaceuticals
REGN
$61.5B
| $5.93M | 3.88% | 12,150 -1,250 | -9% | -$610K |
|
6
AbbVie
ABBV
$372B
| $4.96M | 3.25% | 65,150 +6,550 | +11% | +$499K |
|
|
7
Incyte
INCY
$16.5B
| $4.38M | 2.86% | 59,800 +14,800 | +33% | +$1.08M |
|
8
Oracle
ORCL
$635B
| $4.11M | 2.69% | 85,000 +20,000 | +31% | +$967K |
|
9
AT&T
T
$209B
| $4.02M | 2.63% | 138,000 -12,000 | -8% | -$350K |
|
10
Advanced Micro Devices
AMD
$264B
| $3.87M | 2.53% | 85,000 | – | – |
|
11
Bank of America
BAC
$376B
| $3.56M | 2.33% | 167,500 +7,500 | +5% | +$159K |
|
12
Bristol-Myers Squibb
BMY
$96B
| $3.29M | 2.15% | 59,000 -500 | -0.8% | -$27.9K |
|
13
argenx
ARGX
$43.6B
| $3.16M | 2.07% | 24,000 +2,000 | +9% | +$264K |
|
14
Citigroup
C
$178B
| $3.16M | 2.07% | 75,000 | – | – |
|
|
15
Alnylam Pharmaceuticals
ALNY
$58.5B
| $3.16M | 2.07% | 29,000 -11,000 | -28% | -$1.2M |
|
16
iShares Gold Trust
IAU
$50.6B
| $3.01M | 1.97% | 200,000 | – | – |
|
|
17
Berkshire Hathaway Class B
BRK.B
$1.09T
| $2.74M | 1.79% | +15,000 | New | +$2.74M |
|
18
Amgen
AMGN
$155B
| $2.69M | 1.76% | 13,250 +750 | +6% | +$152K |
|
19
Xencor
XNCR
$580M
| $2.51M | 1.64% | 84,000 +27,575 | +49% | +$824K |
|
20
Fresenius Medical Care
FMS
$15.1B
| $2.18M | 1.43% | 66,500 +29,000 | +77% | +$951K |
|
|
21
Verizon
VZ
$186B
| $2.15M | 1.41% | 40,000 +25,000 | +167% | +$1.34M |
|
|
22
VanEck Gold Miners ETF
GDX
$19B
| $2.07M | 1.36% | +90,000 | New | +$2.07M |
|
|
SGEN
23
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.96M | 1.28% | 17,000 | – | – |
|
|
XLNX
24
DELISTED
Xilinx Inc
XLNX
| $1.95M | 1.28% | 25,000 +9,250 | +59% | +$721K |
|
|
AOD
25
abrdn Total Dynamic Dividend Fund
AOD
$963M
| $1.91M | 1.25% | 289,917 +8,500 | +3% | +$55.9K |
|